[Anti-aggregatory and anticoagulant effects of oligoamines. 9. The pharmacokinetics of N,N',N"-tris-4-(3-iodo-4-methoxyphenyl)-butyl-1,3,5-benzene triethanamine].
Rehse
K
K
Buck
W
W
Wenzel
M
M
D000818:Animals; D000925:Anticoagulants / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010627:Phenethylamines / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D000925:Anticoagulants; C058375:N,N',N''-tris-4-(3-iodo-4-methoxyphenyl)butyl-1,3,5-benzenetriethanamine; D010627:Phenethylamines; D010975:Platelet Aggregation Inhibitors
Antiaggregatorische und anticoagulante Eigenschaften von Oligoaminen, 9. Mitt. Zur Pharmakokinetik von N,N',N"-Tris-4-(3-iod-4-methoxyphenyl)-butyl- 1,3,5-benzol-triethanamin.